Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according to a study published online Sept. 24 in the Journal of the National Cancer Institute.
Nadia Howlader, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues used 2021 incidence data from the Surveillance, Epidemiology, and End Results program to assess the impact of the pandemic on cancer incidence rates in the United States. Observed 2021 cancer incidence rates were compared to expected prepandemic trends, assessed by individual cancer site (breast, prostate, lung and bronchus, pancreas, and thyroid) and stage.
The researchers found that incidence overall and in many cancer sites was close to prepandemic levels, but there was no recovery that incorporated delayed diagnoses from 2020. Exceptions were seen, such as metastatic breast cancer, which had a significantly higher rate than expected (rate ratio, 1.09).
"Overall incidence rates for all cancer sites and the five specific cancer sites examined in this study returned to prepandemic levels. They did not, however, display a rebound to account for potential delayed diagnoses in 2020," the authors write. "Continuous monitoring is necessary to address the long-term consequences of the COVID-19 pandemic on cancer incidence and outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Further Support and Information on COVID-19
Read this next
Few With Abnormal Protein Dipstick Results Have Albuminuria Testing
MONDAY, Sept. 30, 2024 -- Few patients with abnormal protein dipstick results have follow-up albuminuria quantification, according to a research letter published online Oct. 1 in...
No Infections Seen After Transperineal Biopsy for Prostate Cancer
MONDAY, Sept. 30, 2024 -- For patients with suspicion for prostate cancer, transperineal biopsy has similar cancer detection rates as transrectal biopsy but a significantly lower...
Guideline Developed for Opioid Prescribing in Children With Acute Pain
MONDAY, Sept. 30, 2024 -- In a clinical practice guideline issued by the American Academy of Pediatrics and published online Sept. 30 in Pediatrics, recommendations are presented...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.